41 results found.
    
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical Report Preliminary 4Q18 and FY 2018 Results
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical reported preliminary 4Q18 and FY 2018 results.
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
SeaSpine Reports 3Q18 Revenue of $35.8MM, +12.9% vs. 3Q17
SeaSpine picks up momentum, posts 3Q18 revenue of US $35.8MM, +12.9% vs. 3Q17.
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
SeaSpine 2Q18 Revenue +7% vs. 2Q17
SeaSpine announced 2Q18 revenue of US $36.4MM, +6.5% vs. 2Q17, and 1H18 revenue of $69.6MM, +5.3% vs. 1H17. Thi...
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
SeaSpine 1Q18 Revenue Grows 4% YoY
SeaSpine announced 1Q18 revenue of US $33.2MM, +4.1% vs. 1Q17.
Public Orthopaedic Companies: 2017 Revenue and 2018 Sales Drivers
By Julie A. Vetalice The 20 companies tracked in Exhibits 1 and 2 collectively grew +3.0% in 2017 vs. 2016. Individually, you’ll notice some stellar performance in particular segments. (Our final estimates for 2017 orthopaedic industry revenue can be found in
SeaSpine Announces 4Q17, 2017 Revenue
SeaSpine announced 4Q17 revenue of US $34.0MM, +4.5% vs. 4Q16, and 2017 revenue of $131.8MM, +2.3% vs. 2016...
SeaSpine Preliminary 4Q and 2017 Revenue
SeaSpine reported preliminary 4Q17 revenue in the range of US $34.2MM to $34.4MM, +5.8% vs. 4Q16, and a 2017 revenue ran...
Majority of Public Orthopaedic Companies Still on Track for Full-Year Guidance
By Julie A. Vetalice Looking at 3Q17 revenue and reading call transcripts, much was said about unforeseen headwinds that crept in before the close of the year, affecting orthopaedic companies in a variety of ways. Following weather events, oft-cited “softness&rdqu...
SeaSpine Reports 3Q17 Revenue
SeaSpine announced 3Q17 revenue of US $31.7MM, flat vs. 3Q16, and YTD revenue of $97.8MM, +1.6% vs. the prior year...
SeaSpine Reports Preliminary 3Q17 Revenue
SeaSpine announced preliminary 3Q17 revenue of US $31.7MM, flat vs. 3Q16.
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
SeaSpine Posts 2Q17 Revenue
SeaSpine announced 2Q17 revenue of US $34.2MM, +3.0% vs. 2Q16, and 1H17 revenue of $66.1MM, +2.3% vs. 1H16.
SeaSpine Reports Preliminary 2Q17 Revenue
SeaSpine announced preliminary 2Q17 revenue in the range of US $34.0MM to $34.2MM, +3% vs. 2Q16.
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
SeaSpine Posts 1Q17 Revenue
SeaSpine announced 1Q17 revenue of US $31.9MM, +1.6% vs. 1Q16. (U.S. $28.6MM, +0.2%; ex-U.S. $3.3MM, +15.6%)
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
SeaSpine Reports 4Q16 and 2016 Revenue
SeaSpine announced 2016 revenue of US $128.9MM, -3.2% vs. 2015, with 4Q16 revenue of $32.5MM, -6.5% vs. 4...
Globus Medical Preliminary 2016/4Q16 Revenue
Globus Medical announced preliminary unaudited 2016 sales of ~US $564.0MM, with 4Q16 sales of ~$151.6MM
SeaSpine Announces Preliminary 4Q16, Full Year 2016 Revenue
SeaSpine announced preliminary unaudited 2016 sales in the range of ~US $128.8MM and $129.0MM, and 4Q16 sales
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
SeaSpine Posts 3Q16 Revenue
SeaSpine announced 3Q16 revenue of US $31.8MM, -2.7% vs. 3Q15.
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group